Last 12 months
Inside the activity.
2 purchase rows · 31 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 16 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 2 | 2 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 28, 2025 Filed Jan 29, 2025 01:38 UTC |
Bair Teresa BrophyChief Legal Officer
|
SaleCommon Stock | 4,844 | $7.87 | $38,131.48 |
DisclosureSEC source: 0000950170-25-010120 · ownership.xml · nonDerivative · entry 2 Bair Teresa Brophy · CIK 0001813058 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,948 F2 · acquired: Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/24. Read SEC document |
| January 28, 2025 Filed Jan 29, 2025 01:38 UTC |
Bair Teresa BrophyChief Legal Officer
|
SaleCommon Stock | 2,437 | $7.87 | $19,183.82 |
DisclosureSEC source: 0000950170-25-010120 · ownership.xml · nonDerivative · entry 1 Bair Teresa Brophy · CIK 0001813058 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,792 F1 · acquired: Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/16/23. Read SEC document |
| January 28, 2025 Filed Jan 29, 2025 01:54 UTC |
DOYLE THOMAS JAMESSVP, Finance & Accounting
|
SaleCommon Stock | 1,122 | $7.87 | $8,832.27 |
DisclosureSEC source: 0000950170-25-010137 · ownership.xml · nonDerivative · entry 4 DOYLE THOMAS JAMES · CIK 0001910331 · SVP, Finance & Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,193 F4 · acquired: Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/16/23. Read SEC document |
| January 28, 2025 Filed Jan 29, 2025 01:54 UTC |
DOYLE THOMAS JAMESSVP, Finance & Accounting
|
SaleCommon Stock | 699 | $7.87 | $5,502.46 |
DisclosureSEC source: 0000950170-25-010137 · ownership.xml · nonDerivative · entry 3 DOYLE THOMAS JAMES · CIK 0001910331 · SVP, Finance & Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,315 F3 · acquired: Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22. Read SEC document |
| January 28, 2025 Filed Jan 29, 2025 01:54 UTC |
DOYLE THOMAS JAMESSVP, Finance & Accounting
|
SaleCommon Stock | 887 | $7.87 | $6,982.38 |
DisclosureSEC source: 0000950170-25-010137 · ownership.xml · nonDerivative · entry 2 DOYLE THOMAS JAMES · CIK 0001910331 · SVP, Finance & Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,014 F2 · acquired: Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/7/22. Read SEC document |
| January 28, 2025 Filed Jan 29, 2025 01:54 UTC |
DOYLE THOMAS JAMESSVP, Finance & Accounting
|
SaleCommon Stock | 2,241 | $7.87 | $17,640.93 |
DisclosureSEC source: 0000950170-25-010137 · ownership.xml · nonDerivative · entry 1 DOYLE THOMAS JAMES · CIK 0001910331 · SVP, Finance & Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,901 F1 · acquired: Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/24. Read SEC document |
| January 28, 2025 Filed Jan 29, 2025 01:38 UTC |
FORD KATHLEENChief Operating Officer
|
SaleCommon Stock | 1,817 | $7.87 | $14,303.24 |
DisclosureSEC source: 0000950170-25-010118 · ownership.xml · nonDerivative · entry 1 FORD KATHLEEN · CIK 0001785406 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,367 F1 · acquired: Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22. Read SEC document |
| January 28, 2025 Filed Jan 29, 2025 01:38 UTC |
Powl Brian T.Chief Commercial Officer
|
SaleCommon Stock | 1,583 | $7.87 | $12,461.22 |
DisclosureSEC source: 0000950170-25-010116 · ownership.xml · nonDerivative · entry 1 Powl Brian T. · CIK 0001934232 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,667 F1 · acquired: Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/24. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:08 UTC |
Bair Teresa BrophyChief Legal Officer
|
GrantOption to purchase common stock · Derivative | 92,500 | $0.00 Strike: $8.68 | $0.00 |
DisclosureSEC source: 0000950170-25-002062 · ownership.xml · derivative · entry 2 Bair Teresa Brophy · CIK 0001813058 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,500 Underlying: Common Stock · 92,500 shares Expires 2035-01-01 F2 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on the grant date. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:08 UTC |
Bair Teresa BrophyChief Legal Officer
|
GrantCommon Stock | 46,250 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-002062 · ownership.xml · nonDerivative · entry 1 Bair Teresa Brophy · CIK 0001813058 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,229 F1 · shares: Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/26, 1/26/27, 1/26/28 and 1/26/29. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:09 UTC |
DOYLE THOMAS JAMESSVP, Finance & Accounting
|
GrantOption to purchase common stock · Derivative | 42,500 | $0.00 Strike: $8.68 | $0.00 |
DisclosureSEC source: 0000950170-25-002072 · ownership.xml · derivative · entry 4 DOYLE THOMAS JAMES · CIK 0001910331 · SVP, Finance & Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,500 Underlying: Common Stock · 42,500 shares Expires 2035-01-01 F4 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on the grant date. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:09 UTC |
DOYLE THOMAS JAMESSVP, Finance & Accounting
|
GrantCommon Stock | 21,250 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-002072 · ownership.xml · nonDerivative · entry 2 DOYLE THOMAS JAMES · CIK 0001910331 · SVP, Finance & Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,142 F3 · shares: Grant of RSUs. The RSUs vest in full on 1/26/27. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:09 UTC |
DOYLE THOMAS JAMESSVP, Finance & Accounting
|
GrantCommon Stock | 21,250 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-002072 · ownership.xml · nonDerivative · entry 1 DOYLE THOMAS JAMES · CIK 0001910331 · SVP, Finance & Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,892 F1 · shares: Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/26, 1/26/27, 1/26/28 and 1/26/29. F2 · balance_after: Includes 2,499 shares acquired on May 17, 2024 and 50 shares acquired on November 17, 2024 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:07 UTC |
Powl Brian T.Chief Commercial Officer
|
GrantOption to purchase common stock · Derivative | 92,500 | $0.00 Strike: $8.68 | $0.00 |
DisclosureSEC source: 0000950170-25-002056 · ownership.xml · derivative · entry 2 Powl Brian T. · CIK 0001934232 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,500 Underlying: Common Stock · 92,500 shares Expires 2035-01-01 F2 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on the grant date. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:07 UTC |
Powl Brian T.Chief Commercial Officer
|
GrantCommon Stock | 46,250 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-002056 · ownership.xml · nonDerivative · entry 1 Powl Brian T. · CIK 0001934232 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,250 F1 · shares: Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/26, 1/26/27, 1/26/28 and 1/26/29. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:06 UTC |
FORD KATHLEENChief Operating Officer
|
GrantOption to purchase common stock · Derivative | 185,000 | $0.00 Strike: $8.68 | $0.00 |
DisclosureSEC source: 0000950170-25-002049 · ownership.xml · derivative · entry 1 FORD KATHLEEN · CIK 0001785406 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,000 Underlying: Common Stock · 185,000 shares Expires 2035-01-01 F1 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on the grant date. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:05 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
GrantOption to purchase common stock · Derivative | 625,000 | $0.00 Strike: $8.68 | $0.00 |
DisclosureSEC source: 0000950170-25-002046 · ownership.xml · derivative · entry 1 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 625,000 Underlying: Common Stock · 625,000 shares Expires 2035-01-01 F1 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on the grant date. Read SEC document |
| January 02, 2025 Filed Jan 7, 2025 22:48 UTC |
Leoni MollieChief Medical Officer
|
GrantOption to purchase common stock · Derivative | 92,500 | $0.00 Strike: $8.68 | $0.00 |
DisclosureSEC source: 0001415889-25-001052 · form4-01072025_100104.xml · derivative · entry 2 Leoni Mollie · CIK 0002051106 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,500 Underlying: Common Stock · 92,500 shares Expires 2035-01-01 F2 · derivative.exercise_date: The option vests in 48 equal monthly installments commencing on the grant date. Read SEC document |
| January 02, 2025 Filed Jan 7, 2025 22:48 UTC |
Leoni MollieChief Medical Officer
|
GrantCommon Stock | 46,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001052 · form4-01072025_100104.xml · nonDerivative · entry 1 Leoni Mollie · CIK 0002051106 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,216 F1 · shares: Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/26, 1/26/27, 1/26/28 and 1/26/29. Read SEC document |
| January 02, 2025 Filed Jan 7, 2025 17:32 UTC |
Burrows FrancisChief Scientific Officer
|
GrantOption to purchase common stock · Derivative | 185,000 | $0.00 Strike: $8.68 | $0.00 |
DisclosureSEC source: 0001415889-25-001045 · form4-01072025_100138.xml · derivative · entry 1 Burrows Francis · CIK 0002051119 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,000 Underlying: Common Stock · 185,000 shares Expires 2035-01-01 F1 · derivative.exercise_date: The option vests in 48 equal monthly installments commencing on the grant date. Read SEC document |
| November 18, 2024 Filed Nov 19, 2024 21:05 UTC |
FORD KATHLEENChief Operating Officer
|
SaleCommon Stock | 526 | $16.03 | $8,433.73 |
DisclosureSEC source: 0000950170-24-128558 · ownership.xml · nonDerivative · entry 1 FORD KATHLEEN · CIK 0001785406 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,184 F1 · shares: 526 shares were acquired on November 17, 2024 pursuant to the Issuer's Employee Stock Purchase Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $15.78 to $16.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 1,582 shares acquired on May 17, 2024 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| September 13, 2024 Filed Sep 17, 2024 20:10 UTC |
VASCONCELLES MICHAELDirector
|
GrantOption to purchase common stock · Derivative | 17,333 | $0.00 Strike: $20.88 | $0.00 |
DisclosureSEC source: 0000950170-24-107272 · ownership.xml · derivative · entry 2 VASCONCELLES MICHAEL · CIK 0001734755 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,333 Underlying: Common Stock · 17,333 shares Expires 2034-09-12 F2 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant. Read SEC document |
| September 13, 2024 Filed Sep 17, 2024 20:10 UTC |
VASCONCELLES MICHAELDirector
|
GrantOption to purchase common stock · Derivative | 52,000 | $0.00 Strike: $20.88 | $0.00 |
DisclosureSEC source: 0000950170-24-107272 · ownership.xml · derivative · entry 1 VASCONCELLES MICHAEL · CIK 0001734755 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,000 Underlying: Common Stock · 52,000 shares Expires 2034-09-12 F1 · derivative.exercise_date: This option vests in three equal annual installments commencing on the one year anniversary of the date of grant. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:30 UTC |
Szela Mary TDirector
|
GrantOption to purchase common stock · Derivative | 26,000 | $0.00 Strike: $21.79 | $0.00 |
DisclosureSEC source: 0000950170-24-070702 · ownership.xml · derivative · entry 1 Szela Mary T · CIK 0001410289 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,000 Underlying: Common Stock · 26,000 shares Expires 2034-06-04 F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:30 UTC |
Parks Diane L.Director
|
GrantOption to purchase common stock · Derivative | 26,000 | $0.00 Strike: $21.79 | $0.00 |
DisclosureSEC source: 0000950170-24-070700 · ownership.xml · derivative · entry 1 Parks Diane L. · CIK 0001781026 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,000 Underlying: Common Stock · 26,000 shares Expires 2034-06-04 F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:30 UTC |
SCHAFER CAROLDirector
|
GrantOption to purchase common stock · Derivative | 26,000 | $0.00 Strike: $21.79 | $0.00 |
DisclosureSEC source: 0000950170-24-070699 · ownership.xml · derivative · entry 1 SCHAFER CAROL · CIK 0001272181 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,000 Underlying: Common Stock · 26,000 shares Expires 2034-06-04 F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:30 UTC |
Malley ThomasDirector
|
GrantOption to purchase common stock · Derivative | 26,000 | $0.00 Strike: $21.79 | $0.00 |
DisclosureSEC source: 0000950170-24-070698 · ownership.xml · derivative · entry 1 Malley Thomas · CIK 0001403322 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,000 Underlying: Common Stock · 26,000 shares Expires 2034-06-04 F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:30 UTC |
Hasnain FaheemDirector
|
GrantOption to purchase common stock · Derivative | 26,000 | $0.00 Strike: $21.79 | $0.00 |
DisclosureSEC source: 0000950170-24-070707 · ownership.xml · derivative · entry 1 Hasnain Faheem · CIK 0001352620 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,000 Underlying: Common Stock · 26,000 shares Expires 2034-06-04 F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:30 UTC |
Collins Helen LouiseDirector
|
GrantOption to purchase common stock · Derivative | 26,000 | $0.00 Strike: $21.79 | $0.00 |
DisclosureSEC source: 0000950170-24-070697 · ownership.xml · derivative · entry 1 Collins Helen Louise · CIK 0001701247 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,000 Underlying: Common Stock · 26,000 shares Expires 2034-06-04 F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant. Read SEC document |
| May 20, 2024 Filed May 20, 2024 22:30 UTC |
Bair Teresa BrophyChief Legal Officer
|
SaleCommon Stock | 2,615 | $22.15 | $57,916.24 |
DisclosureSEC source: 0000950170-24-062585 · ownership.xml · nonDerivative · entry 1 Bair Teresa Brophy · CIK 0001813058 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,979 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 22, 2023. F2 · shares: 2615 shares were acquired on May 17, 2024 pursuant to the Issuer's Employee Stock Purchase Plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $22.06 to $22.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · ownership.direct: The reported sale of 2,615 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 22, 2023. Read SEC document |
| January 30, 2024 Filed Jan 31, 2024 22:30 UTC |
DALE STEPHENChief Medical Officer
|
SaleCommon Stock | 4,825 | $21.55 | $103,979.72 |
DisclosureSEC source: 0000950170-24-009493 · ownership.xml · nonDerivative · entry 3 DALE STEPHEN · CIK 0001821709 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,817 F4 · price: This transaction was executed in multiple trades at prices ranging from $18.53 to $22.06. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · acquired: This transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2022. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 22:30 UTC |
Bair Teresa BrophyChief Legal Officer
|
SaleCommon Stock | 2,053 | $17.80 | $36,544.43 |
DisclosureSEC source: 0000950170-24-009495 · ownership.xml · nonDerivative · entry 1 Bair Teresa Brophy · CIK 0001813058 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,979 F1 · acquired: Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/23. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 22:30 UTC |
FORD KATHLEENChief Operating Officer
|
SaleCommon Stock | 1,496 | $17.80 | $26,629.55 |
DisclosureSEC source: 0000950170-24-009494 · ownership.xml · nonDerivative · entry 1 FORD KATHLEEN · CIK 0001785406 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,602 F1 · acquired: Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22. F2 · balance_after: Includes 1,884 shares acquired on November 17, 2023 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 22:30 UTC |
DOYLE THOMAS JAMESSVP, Finance & Accounting
|
SaleCommon Stock | 963 | $17.80 | $17,141.88 |
DisclosureSEC source: 0000950170-24-009496 · ownership.xml · nonDerivative · entry 3 DOYLE THOMAS JAMES · CIK 0001910331 · SVP, Finance & Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,093 F3 · acquired: Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/16/23. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 22:30 UTC |
DOYLE THOMAS JAMESSVP, Finance & Accounting
|
SaleCommon Stock | 761 | $17.80 | $13,546.18 |
DisclosureSEC source: 0000950170-24-009496 · ownership.xml · nonDerivative · entry 2 DOYLE THOMAS JAMES · CIK 0001910331 · SVP, Finance & Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,056 F2 · acquired: Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/7/22. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 22:30 UTC |
DOYLE THOMAS JAMESSVP, Finance & Accounting
|
SaleCommon Stock | 594 | $17.80 | $10,573.50 |
DisclosureSEC source: 0000950170-24-009496 · ownership.xml · nonDerivative · entry 1 DOYLE THOMAS JAMES · CIK 0001910331 · SVP, Finance & Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,817 F1 · acquired: Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 22:30 UTC |
DALE STEPHENChief Medical Officer
|
SaleCommon Stock | 2,758 | $17.80 | $49,093.78 |
DisclosureSEC source: 0000950170-24-009493 · ownership.xml · nonDerivative · entry 2 DALE STEPHEN · CIK 0001821709 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,642 F2 · acquired: Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/16/23. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 22:30 UTC |
DALE STEPHENChief Medical Officer
|
SaleCommon Stock | 4,400 | $17.80 | $78,322.20 |
DisclosureSEC source: 0000950170-24-009493 · ownership.xml · nonDerivative · entry 1 DALE STEPHEN · CIK 0001821709 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,400 F1 · acquired: Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22. Read SEC document |
| January 24, 2024 Filed Jan 26, 2024 22:10 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
SaleCommon Stock | 84,107 | $20.23 | $1,701,484.61 |
DisclosureSEC source: 0000950170-24-008020 · ownership.xml · nonDerivative · entry 4 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 559 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 20, 2022. Read SEC document |
| January 24, 2024 Filed Jan 26, 2024 22:10 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
Exercise / conversionCommon Stock | 84,107 | $6.15 | $517,258.05 |
DisclosureSEC source: 0000950170-24-008020 · ownership.xml · nonDerivative · entry 3 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,666 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 20, 2022. Read SEC document |
| January 24, 2024 Filed Jan 26, 2024 22:10 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
SaleCommon Stock | 6,945 | $20.23 | $140,497.35 |
DisclosureSEC source: 0000950170-24-008020 · ownership.xml · nonDerivative · entry 2 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 559 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 20, 2022. Read SEC document |
| January 24, 2024 Filed Jan 26, 2024 22:10 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
Exercise / conversionCommon Stock | 6,945 | $4.80 | $33,336.00 |
DisclosureSEC source: 0000950170-24-008020 · ownership.xml · nonDerivative · entry 1 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,504 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 20, 2022. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:07 UTC |
Bair Teresa BrophyChief Legal Officer
|
GrantOption to purchase common stock · Derivative | 92,500 | $0.00 Strike: $15.36 | $0.00 |
DisclosureSEC source: 0000950170-24-001847 · ownership.xml · derivative · entry 2 Bair Teresa Brophy · CIK 0001813058 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,500 Underlying: Common Stock · 92,500 shares Expires 2034-01-01 F3 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on the grant date. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:07 UTC |
Bair Teresa BrophyChief Legal Officer
|
GrantCommon Stock | 46,250 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-001847 · ownership.xml · nonDerivative · entry 1 Bair Teresa Brophy · CIK 0001813058 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,032 F1 · shares: Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/25, 1/26/26, 1/26/27 and 1/26/28. F2 · balance_after: Includes 1,657 shares acquired on May 17, 2023 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:08 UTC |
DOYLE THOMAS JAMESSVP, Finance & Accounting
|
GrantOption to purchase common stock · Derivative | 42,500 | $0.00 Strike: $15.36 | $0.00 |
DisclosureSEC source: 0000950170-24-001850 · ownership.xml · derivative · entry 3 DOYLE THOMAS JAMES · CIK 0001910331 · SVP, Finance & Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,500 Underlying: Common Stock · 42,500 shares Expires 2034-01-01 F3 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on the grant date. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:08 UTC |
DOYLE THOMAS JAMESSVP, Finance & Accounting
|
GrantCommon Stock | 21,250 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-001850 · ownership.xml · nonDerivative · entry 1 DOYLE THOMAS JAMES · CIK 0001910331 · SVP, Finance & Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,411 F1 · shares: Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/25, 1/26/26, 1/26/27 and 1/26/28. F2 · balance_after: Includes 1,489 shares acquired on May 17, 2023 and 206 shares acquired on November 17, 2023 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:07 UTC |
Powl Brian T.Chief Commercial Officer
|
GrantOption to purchase common stock · Derivative | 30,000 | $0.00 Strike: $15.36 | $0.00 |
DisclosureSEC source: 0000950170-24-001849 · ownership.xml · derivative · entry 2 Powl Brian T. · CIK 0001934232 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2034-01-01 F2 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on the grant date. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:07 UTC |
Powl Brian T.Chief Commercial Officer
|
GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-001849 · ownership.xml · nonDerivative · entry 1 Powl Brian T. · CIK 0001934232 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 F1 · shares: Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/25, 1/26/26, 1/26/27 and 1/26/28. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:07 UTC |
FORD KATHLEENChief Operating Officer
|
GrantOption to purchase common stock · Derivative | 185,000 | $0.00 Strike: $15.36 | $0.00 |
DisclosureSEC source: 0000950170-24-001846 · ownership.xml · derivative · entry 1 FORD KATHLEEN · CIK 0001785406 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,000 Underlying: Common Stock · 185,000 shares Expires 2034-01-01 F1 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on the grant date. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:06 UTC |
DALE STEPHENChief Medical Officer
|
GrantOption to purchase common stock · Derivative | 185,000 | $0.00 Strike: $15.36 | $0.00 |
DisclosureSEC source: 0000950170-24-001843 · ownership.xml · derivative · entry 1 DALE STEPHEN · CIK 0001821709 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,000 Underlying: Common Stock · 185,000 shares Expires 2034-01-01 F1 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.